<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04220268</url>
  </required_header>
  <id_info>
    <org_study_id>GGN-family</org_study_id>
    <nct_id>NCT04220268</nct_id>
  </id_info>
  <brief_title>A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History.</brief_title>
  <acronym>GGN-F</acronym>
  <official_title>Clinical Database and Biobank of Pulmonary Ground Glass Nodules Patients With Family History, a Prospective Cohort Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Provincial People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present prospective cohort study (GGN-F) is to study the family aggregation of
      pulmonary ground glass nodules via the questionnaire survey and to investigate the underlying
      genetic mechanism via the biobank.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In recent years, with the development of low-dose chest CT screening, more and more ground
      glass nodules have been found. Meanwhile, presenting as Ground-glass nodule (GGN), the
      early-stage lung adenocarcinoma patients with lung cancer family history have been emerging
      increasing in recent years in East Asian.

      This prospective cohort study, with both a cross-sectional and a longitudinal part, will
      include patients with pulmonary ground glass nodule, which were proven malignant disease.

      All participants will be asked to complete questionnaire to build the clinical database of
      GGN patients with detailed family history. Furthermore, blood and surgical tumor samples will
      be collected as a specific biobank. And the blood samples of other family members of
      participants will be collected, with their consent and knowledge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 5, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 5, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>The prevalence of family aggregation of pulmonary ground glass nodule.</measure>
    <time_frame>1 week</time_frame>
    <description>To investigate the aggregation of pulmonary ground glass nodule among first-degree relatives of participants via the questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Susceptibility genetic events related to the family aggregation of ground glass nodules.</measure>
    <time_frame>1 month</time_frame>
    <description>To investigate the underlying susceptibility genetic loci which concern with familial inheritance of ground glass nodule.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Family Research</condition>
  <arm_group>
    <arm_group_label>Participants</arm_group_label>
    <description>All the patients with proved malignant ground glass nodule will be enrolled.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and surgical tumor samples of all the participants will be collected. Moreover, blood
      samples of other family members of participants will be collected, with their consent and
      knowledge.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All the patients with pulmonary ground glass nodules and pathological proved malignant
        disease will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients with informed consent;

          2. patients with pulmonary ground glass nodule.

          3. pathological proved early stage lung cancer.

        Exclusion Criteria:

        1.not included in the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenzhao Zhong, Phã€‚D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangdong Provincial People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jia-Tao Zhang, Ph.D</last_name>
    <phone>+86-83827812-51311</phone>
    <email>18820792959@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rui Fu, MD</last_name>
    <phone>+86-83827812-51311</phone>
    <email>13rfu@stu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia-Tao Zhang</last_name>
      <phone>+86-13609777314</phone>
      <email>18820792959@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Wen-Zhao Zhong</last_name>
      <phone>+86-13609777314</phone>
      <email>13609777314@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Dai J, Lv J, Zhu M, Wang Y, Qin N, Ma H, He YQ, Zhang R, Tan W, Fan J, Wang T, Zheng H, Sun Q, Wang L, Huang M, Ge Z, Yu C, Guo Y, Wang TM, Wang J, Xu L, Wu W, Chen L, Bian Z, Walters R, Millwood IY, Li XZ, Wang X, Hung RJ, Christiani DC, Chen H, Wang M, Wang C, Jiang Y, Chen K, Chen Z, Jin G, Wu T, Lin D, Hu Z, Amos CI, Wu C, Wei Q, Jia WH, Li L, Shen H. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med. 2019 Oct;7(10):881-891. doi: 10.1016/S2213-2600(19)30144-4. Epub 2019 Jul 17.</citation>
    <PMID>31326317</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 5, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>January 5, 2020</last_update_submitted>
  <last_update_submitted_qc>January 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong Provincial People's Hospital</investigator_affiliation>
    <investigator_full_name>Wen-zhao ZHONG</investigator_full_name>
    <investigator_title>Porfessor</investigator_title>
  </responsible_party>
  <keyword>Ground glass nodule</keyword>
  <keyword>Family aggregation</keyword>
  <keyword>Hereditary susceptibility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

